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Middle East respiratory syndrome coronavirus (MERS-CoV) cur-
rently spreads in humans and causes ∼36% fatality in infected
patients. Believed to have originated from bats, MERS-CoV is ge-
netically related to bat coronaviruses HKU4 and HKU5. To under-
stand how bat coronaviruses transmit to humans, we investigated
the receptor usage and cell entry activity of the virus-surface spike
proteins of HKU4 and HKU5. We found that dipeptidyl peptidase 4
(DPP4), the receptor for MERS-CoV, is also the receptor for HKU4,
but not HKU5. Despite sharing a common receptor, MERS-CoV and
HKU4 spikes demonstrated functional differences. First, whereas
MERS-CoV prefers human DPP4 over bat DPP4 as its receptor,
HKU4 shows the opposite trend. Second, in the absence of exog-
enous proteases, both MERS-CoV and HKU4 spikes mediate pseu-
dovirus entry into bat cells, whereas only MERS-CoV spike, but not
HKU4 spike, mediates pseudovirus entry into human cells. Thus,
MERS-CoV, but not HKU4, has adapted to use human DPP4 and
human cellular proteases for efficient human cell entry, contribut-
ing to the enhanced pathogenesis of MERS-CoV in humans. These
results establish DPP4 as a functional receptor for HKU4 and host
cellular proteases as a host range determinant for HKU4. They also
suggest that DPP4-recognizing bat coronaviruses threaten human
health because of their spikes’ capability to adapt to human cells
for cross-species transmissions.
As of June 16, 2014, the recently emerged Middle East re-spiratory syndrome coronavirus (MERS-CoV) had infected
701 people, with a fatality rate of ∼36% (www.who.int/csr/don/
2014_06_16_mers/en/), and had demonstrated the capability for
human-to-human transmission (1, 2). Alarmingly, coronavirus
surveillance studies have suggested that MERS-CoV originated
from animals, with bats as the likely natural reservoir and camels
as the likely intermediate hosts (3–6). Hence, cross-species
transmission of MERS-CoV from bats to humans, either directly
or through camels, poses a constant and long-term threat to hu-
man health. Phylogenetic analysis has revealed that MERS-CoV
is genetically related to two bat coronaviruses, HKU4 and HKU5
(7-9). Understanding the pathogenesis and potential cross-species
transmissibility of these bat coronaviruses is critical for evaluating
long-term emerging disease potentials and for preventing and
controlling the spread of bat-originated coronaviruses in humans.
This study investigates the receptor usage and cell entry mecha-
nisms of HKU4 and HKU5, providing insight into how MERS-
CoV and MERS-related bat coronaviruses can cross species
barriers, adapt to human cells, and gain infectivity in humans.
Receptor recognition has been established as an important
determinant of the host range and tropism of coronaviruses (10,
11). An envelope-anchored spike protein mediates coronavirus
entry into host cells by first binding to a host receptor through its
S1 subunit and then fusing the host and viral membranes via its
S2 subunit. Coronaviruses recognize a wide range of receptors,
including proteins and sialic acids (12). MERS-CoV uses dipeptidyl
peptidase 4 (DPP4) as its receptor (13). A defined receptor-bind-
ing domain (RBD) in MERS-CoV spike S1 subunit binds human
DPP4 with high affinity (14–18). MERS-CoV RBD shares 56%
and 54% sequence similarity with the corresponding S1 domain in
HKU4 and HKU5, respectively (Fig. S1A) (9), raising the possi-
bility that HKU4 and HKU5 may also use DPP4 as their receptor.
However, previous studies showed that receptor recognition by
coronaviruses is sensitive to residue changes in coronavirus RBDs
(19). For example, one or two residue changes in the RBD of
another bat-originated coronavirus, severe acute respiratory syn-
drome coronavirus (SARS-CoV), can dictate whether SARS-CoV
uses human angiotensin-converting enzyme 2 as its receptor for
efficient human infections (19–22). Therefore, investigating the
receptors of HKU4 and HKU5 is important for understanding
their potential threats to human health and for delineating the
causes of MERS-CoV infections in humans.
Coronavirus entry into host cells is limited not only by receptor
recognition but also by membrane fusion. To fuse host and viral
membranes, coronavirus spikes need to be cleaved at the S1/S2
boundary by host proteases (23–27). The availability of these
host proteases to coronaviruses and the specificities of these host
proteases on coronavirus spikes can contribute to the host range
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and tropism of coronaviruses. Coronavirus-spike-processing host
proteases may include proprotein convertases from the virus-
producing cells (e.g., furin), proteases from the extracellular
environment (e.g., elastase), proteases on the cell surface of
virus-targeting cells (e.g., type 2 transmembrane serine protease,
or TMPRSS2), and proteases in the endosomes of virus-targeting
cells (e.g., cathepsin L) (23, 24). Bat-originated and human-
infecting coronaviruses MERS-CoV and SARS-CoV both use
cell-surface protease TMPRSS2 and endosomal protease
cathepsins L for human cell entry, although proteases from the
extracellular environment may also facilitate the cell entry pro-
cess (23–30). However, the mechanisms for human cell entry by
bat coronaviruses are poorly understood, leaving a critical
missing link in the bat-to-human transmission of coronaviruses.
Therefore, examining the cell entry of HKU4 and HKU5 can
provide novel knowledge of the causes of MERS-CoV (and
SARS-CoV) infections in humans.
In this study, we have elucidated the receptor usage and cell
entry activity of HKU4 and HKU5 spikes compared with MERS-
CoV spike. Our study illuminates the mechanisms by which bat
coronaviruses adapt to human cells during cross-species trans-
mission events and provides valuable knowledge that can be used
to evaluate emerging disease potentials of bat coronaviruses and
to prevent and control the future spread of bat coronaviruses
in humans.
Results
We expressed and purified the S1 domains of four viruses
(HKU4, HKU5, MERS-CoV, and SARS-CoV), as well as DPP4
ectodomain from two species (human and bat), using procedures
described previously (14, 22). Here the S1 domains of HKU4
(residues 372–593) and HKU5 (residues 375–586) correspond to
the DPP4-binding RBD in MERS-CoV spike (residues 367–588)
(Fig. S1A). The two bat species from which HKU4 and HKU5
were isolated belong to the same family, but different genera (Fig.
S1B) (7–9). To understand coronavirus spike/DPP4 interactions,
the DPP4 and coronavirus spike genes under investigation need
to come from the same or similar bat species. Because the DPP4
genes from the above two bat species are unavailable, we chose
the DPP4 gene from another bat species in the same genus as the
one from which HKU5 was isolated (Fig. S1B). All of the
recombinant proteins were purified to high homogeneity (Fig. S2)
and subsequently used in the following biochemical studies.
Using three alternative approaches, we characterized the
binding interactions between the S1 domain of each virus and
DPP4 from each species. AlphaScreen protein–protein binding
assay showed that whereas the MERS-CoV S1 domain bound
human DPP4 (hDPP4) with significantly higher affinity than it
bound bat DPP4 (bDPP4), the corresponding HKU4 S1 domain
bound bDPP4 slightly better than it bound hDPP4 (Fig. 1A). In
contrast, the HKU5 S1 domain did not bind hDPP4 or bDPP4.
As a control, the SARS-CoV S1 domain only bound its own
receptor human angiotensin-converting enzyme 2, but not
hDPP4 or bDPP4. Pull-down assay revealed that hDPP4 was
more efficient than bDPP4 at pulling down the MERS-CoV S1
domain from solution, whereas both hDPP4 and bDPP4 pulled
down the HKU4 S1 domain efficiently (Fig. 1B). In contrast,
neither hDPP4 nor bDPP4 pulled down the SARS-CoV or
HKU5 S1 domain. Pseudovirus inhibition assay demonstrated
that the HKU4 S1 domain, but not the HKU5 or SARS-CoV S1
domain, inhibited MERS-CoV-spike-mediated pseudovirus en-
try into HEK293T cells exogenously expressing hDPP4 or
bDPP4 [HEK293T cells are human embryonic kidney cells that
do not endogenously express DPP4 (31)]. This indicates that the
HKU4 S1 domain and MERS-CoV-spike-packaged pseudovi-
ruses competed for the same DPP4 receptor on HEK293T cell
surface (Fig. 1C). Taken together, these results showed that the
HKU4 S1 domain, but not the HKU5 S1 domain, binds both
hDPP4 and bDPP4, and that the MERS-CoV S1 domain binds
hDPP4 significantly better than it binds bDPP4, whereas the
HKU4 S1 domain binds bDPP4 slightly better than it binds
hDPP4. These results strongly suggest that HKU4 spike, but not
HKU5 spike, uses DPP4 as its receptor and that the HKU4 S1
domain is the DPP4-binding RBD.
To confirm that DPP4 is the receptor for HKU4 spike, we
investigated whether HKU4 spike could mediate viral entry into
DPP4-expressing human cells. Because live HKU4 virus has
never been successfully cultured, it is not an option to use live
HKU4 virus in this study. Instead, we performed an HKU4-
spike-mediated pseudovirus entry assay. To this end, retroviruses
pseudotyped with HKU4 spike were used to enter HEK293T
cells exogenously expressing either hDPP4 or bDPP4 on their
surface. Surprisingly, HKU4 spike failed to mediate pseudovirus
entry into these DPP4-expressing HEK293T cells (Fig. 2A). As
Fig. 1. Binding interactions between HKU4 spike and DPP4. (A) AlphaScreen
assay showing the direct binding interactions between the coronavirus spike
S1 domains and hDPP4 or bDPP4. Binding affinity was characterized as
AlphaScreen counts. Error bars indicate SEM (two-tailed t test, *P < 0.05,
***P < 0.001; n = 3). (B) Pull-down assay showing the direct binding inter-
actions between the coronavirus S1 domains and hDPP4 or bDPP4. His6-
tagged hDPP4 or bDPP4 was incubated with each of the Fc-tagged corona-
virus S1 domains. The S1 domain/DPP4 complex was then precipitated with
nickel-nitrilotriacetic acid beads. Binding affinity was characterized as
Western blotting on the precipitated Fc-tagged coronavirus S1 domains. (C)
Inhibition of MERS-CoV-spike-mediated pseudovirus entry by the HKU4 S1
domain. HEK293T cells expressing hDPP4 or bDPP4 were preincubated with
gradient concentrations of purified coronavirus S1 domains and then
infected by MERS-CoV-spike-packaged pseudoviruses expressing luciferase.
The pseudovirus entry efficiency was characterized as luciferase activity ac-
companying the entry and normalized relative to the entry in the absence
of any coronavirus S1 domain. Error bars indicate SEM (n = 3).
Yang et al. PNAS | August 26, 2014 | vol. 111 | no. 34 | 12517
M
IC
RO
BI
O
LO
G
Y
a comparison, MERS-CoV spike efficiently mediated pseudovi-
rus entry into hDPP4-expressing HEK293T cells, but less effi-
ciently into bDPP4-expressing HEK293T cells (Fig. 2B).
However, when treated with trypsin, HKU4-spike-packaged
pseudoviruses entered both hDPP4- and bDPP4-expressing
HEK293T efficiently. As a comparison, trypsin treatment had
little effect on MERS-CoV-spike-mediated pseudovirus entry
into DPP4-expressing HEK293T cells. To validate these findings,
we performed two control experiments to ensure that HKU4-
spike-mediated entry depended on both HKU4 spike and DPP4.
First, after trypsin treatment, HKU4-spike-pseudotyped retro-
viruses could not enter HEK293T cells not expressing DPP4
(Fig. 2A). Second, retroviruses not pseudotyped with HKU4
spike could not enter DPP4-expressing HEK293T cells (Fig. 2C).
Overall, these results support two conclusions: DPP4 is the
functional receptor for HKU4 spike, and exogenous trypsin is
needed for HKU4-spike-mediated, but not MERS-CoV-spike-
mediated, pseudovirus entry into human cells.
Further confirmation that DPP4 is the receptor for HKU4
spike came from an examination of whether anti-hDPP4
polyclonal antibodies could competitively block the interactions
between HKU4 spike and hDPP4. First, dot blot hybridization
assay showed that the antibodies almost completely blocked the
binding between HKU4 RBD and hDPP4 and significantly
inhibited the binding between MERS-CoV RBD and hDPP4
(Fig. S3A). In contrast, the antibodies did not block the binding
between HKU4 or MERS-CoV RBD and bDPP4, suggesting
that the antibodies did not target bDPP4. Second, pseudovirus
neutralization assay revealed that the antibodies efficiently
blocked both HKU4- and MERS-CoV-spike-mediated entry into
hDPP4-expressing HEK293T cells, but not bDPP4-expressing
cells (Fig. S3B). These results demonstrated that anti-hDPP4
antibodies competed with HKU4 spike for the binding sites on
hDPP4, further confirming that DPP4 is the functional receptor
for HKU4 spike.
To further investigate the cell entry mechanism of HKU4, we
repeated the pseudovirus entry assay using Huh-7 cells (human
liver cells), Calu-3 cells (human lung cells), and MRC-5 cells
(human lung cells), all of which endogenously express hDPP4
(30-32). The results again showed that exogenous trypsin was
Fig. 2. HKU4- and MERS-CoV-spike-mediated pseudovirus entry into human cells. Retroviruses pseudotyped with HKU4 spike (A), MERS-CoV spike (B), or no
spike (mock) (C) were incubated with gradient concentrations of trypsin and used to enter HEK293T cells (exogenously expressing hDPP4, bDPP4, or no DPP4,
respectively). The pseudovirus entry efficiency was characterized as luciferase activity accompanying the entry. Error bars indicate SEM (n = 4).
Fig. 3. Effects of human TMPRSS2 on HKU4- or MERS-
CoV-spike-mediated pseudovirus entry into human
cells. Retroviruses pseudotyped with HKU4 spike or
MERS-CoV spike were pretreated with no trypsin, 20
μg/mL trypsin, or 100 μg/mL trypsin and used to enter
Huh-7 cells or Huh-7 cells exogenously expressing hu-
man TMPRSS2. The pseudovirus entry efficiency was
characterized as luciferase activity accompanying the
entry. Error bars indicate SEM (two-tailed t test, N.S.,
P > 0.05; n = 4).
12518 | www.pnas.org/cgi/doi/10.1073/pnas.1405889111 Yang et al.
needed for HKU4-spike-mediated, but not MERS-CoV-spike-
mediated, pseudovirus entry into Huh-7, Calu-3, and MRC-5
cells (Fig. S4). Thus, our finding on the effects of trypsin on
HKU4- and MERS-CoV-spike-mediated entry can be extended
to different types of human cells.
What human cellular proteases process MERS-CoV spike, but
not HKU4 spike? To address this question, we looked into all
three stages in which human cellular proteases may play a role
in coronavirus-spike-mediated cell entry. First, by performing
Western blot on MERS-CoV- and HKU4-spike-packaged
pseudoviruses, we found that MERS-CoV spike, but not HKU4
spike, had been partially cleaved coming out of virus-producing
HEK293T cells (Fig. S5). Moreover, HKU4 spike was cleaved by
exogenous trypsin (Fig. S5). Thus, MERS-CoV spike, but not
HKU4 spike, can be partially processed in virus-producing cells
by human endogenous proteases. The processing may be ach-
ieved potentially by human proprotein convertases. Second, we
carried out the pseudovirus entry assay using Huh-7 cells exog-
enously expressing human TMPRSS2 [Huh-7 cells do not en-
dogenously express TMPRSS2 (33)]. The results showed that
human TMPRSS2 enhanced MERS-CoV-spike-mediated, but
not HKU4-spike-mediated, pseudovirus entry (Fig. 3). Third, we
explored the role of human endosomal proteases in MERS-
CoV- and HKU4-spike-mediated pseudovirus entry into Huh-7
cells, using two types of inhibitors: endosomal acidification in-
hibitor NH4Cl and endosomal protease inhibitor E-64d [which
inhibits endosomal cathepsins L, B, H, etc (34)] (Fig. 4). MERS-
CoV-spike-mediated entry was significantly inhibited by both
NH4Cl and E-64d, revealing the critical role of endosomal pro-
teases in MERS-CoV-spike-mediated entry (the higher-than-
baseline level of pseudovirus entry in the presence of NH4Cl or
E-64d is probably a result of the prior partial processing of MERS-
CoV spike during virus packaging and release). In contrast, these
inhibitors showed little effect on HKU4-spike-mediated entry.
Because HKU4 spike fails to transduce the same cell line whose
endosomal proteases activate MERS-CoV spike, HKU4 spike
most likely cannot be activated by human endosomal proteases.
Overall, these results have demonstrated that MERS-CoV spike,
but not HKU4 spike, can be processed by human cellular pro-
teases from three different stages of virus infection: virus pack-
aging and release, viral attachment to human cell surface, and
viral endocytosis.
Finally, we investigated whether HKU4 and MERS-CoV
spikes can mediate pseudovirus entry into bat cells. We repeated
pseudovirus entry assay, using Tb1-Lu cells (bat lung cells) that
exogenously express hDPP4 or bDPP4. The results show that in
the absence of trypsin, both HKU4 and MERS-CoV spikes ef-
ficiently mediated pseudovirus entry into Tb1-Lu cells, even
though trypsin could further enhance HKU4-spike-mediated
pseudovirus entry into Tb1-Lu cells (Fig. 5). In a control ex-
periment, Tb1-Lu cells without exogenously expressed hDPP4 or
bDPP4 failed to support MERS-CoV- or HKU4-spike-mediated
pseudovirus entry, indicating a lack of endogenously expressed
DPP4 in Tb1-Lu cells. These results revealed that in the pres-
ence of an appropriate receptor, activation by exogenous pro-
teases is not a requirement for HKU4- or MERS-CoV-spike-
mediated pseudovirus entry into bat cells.
Discussion
This study has characterized the receptor usage and cell entry of
MERS-related bat coronaviruses HKU4 and HKU5 compared
with bat-originated but human-infecting MERS-CoV. Because
HKU4 and HKU5 had never infected human cells, this study
provided an opportunity to understand human cell adaptations
by MERS-CoV. Through comparative analysis of these viruses,
this study not only has identified the functional receptor for
HKU4 but also has revealed the functional differences between
MERS-CoV and HKU4 spikes in their adaptations to use human
receptor and cellular proteases for human cell entry.
Fig. 4. Role of human endosomal proteases in HKU4- and MERS-CoV-spike-mediated entry into human cells. Huh-7 cells were first preincubated with
endosomal acidification inhibitor NH4Cl or endosomal protease inhibitor E-64d at the indicated concentrations. Then the cells were infected by HKU4- or
MERS-CoV-spike-pseudotyped retroviruses that had been pretreated or not pretreated with 100 μg/mL trypsin. The pseudovirus entry efficiency was char-
acterized as luciferase activity accompanying the entry. Error bars indicate SEM (n = 3).
Fig. 5. HKU4- and MERS-CoV-spike-mediated pseu-
dovirus entry into bat cells. Retroviruses pseudotyped
with HKU4 spike (A), MERS-CoV spike (B), or no spike
(mock) (C) were incubated with gradient concen-
trations of trypsin and used to enter Tb1-Lu bat cells
(exogenously expressing hDPP4, bDPP4, or no DPP4,
respectively). The pseudovirus entry efficiency was
characterized as luciferase activity accompanying the
entry. Error bars indicate SEM (n = 4).
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First, using a combination of experimental approaches in-
cluding AlphaScreen, protein pull down, dot blot hybridization,
pseudovirus inhibition, pseudovirus entry, and antibody neu-
tralization, this study has established DPP4 as the functional
receptor for HKU4. Although HKU4 spike and bDPP4 are from
two different bat species (Fig. S1B), the positive interaction
between the two proteins suggests that HKU4 spike should also
interact positively with bDPP4 from its own bat species. Indeed,
our study shows that both hDPP4 and bDPP4 are efficient
receptors for HKU4 spike, although humans and bats are only
remotely related species. In contrast, HKU5 spike does not use
DPP4 as its receptor, despite sharing sequence similarity with
MERS-CoV and HKU4 spikes. Again, this is unlikely because of
the different bat species from which HKU5 and bDPP4 were
isolated, but is a result of two deletions in the presumable DPP4-
binding region of the HKU5 S1 domain (Fig. S1A). Moreover,
whereas MERS-CoV spike binds hDPP4 with significantly higher
affinity than it binds bDPP4, HKU4 spike slightly prefers bDPP4
over hDPP4. MERS-CoV’s preference for hDPP4 over bDPP4
as its receptor is consistent with a recent finding (35). Thus, it is
likely that MERS-CoV spike has evolved to use hDPP4 effi-
ciently but has become less effective in recognizing bDPP4,
whereas HKU4 spike has not evolved adaptive mutations to
promote efficient hDPP4 usage.
Second, using exogenous trypsin, endosomal acidification and
protease inhibitors, and pseudovirus entry into various types of
human and bat cells, this study has revealed that human cellular
proteases can activate MERS-CoV-spike-mediated, but not
HKU4-spike-mediated, pseudovirus entry into human cells.
These human cellular proteases act on different stages of
MERS-CoV-spike-mediated pseudovirus entry and include hu-
man endogenous proteases (e.g., proprotein convertases) acting
during virus packaging and release, human TMPRSS2 acting
during viral attachment to human cell surface, and human
endosomal cathepsins acting during viral endocytosis. Exogenous
proteases contribute to, but are not essential for, MERS-CoV
entry into human cells exogenously expressing low-affinity DPP4
homologs (35). In contrast, an exogenous protease is essential
for HKU4-spike-mediated entry into human cells. However,
both MERS-CoV and HKU4 spikes can mediate efficient
pseudovirus entry into bat cells, suggesting that bat cellular
proteases can process both MERS-CoV and HKU4 spikes. Be-
cause at this time, little is known about the functions of bat
cellular proteases, future research will be needed to understand
how coronavirus spikes mediate virus entry into bat cells. Nev-
ertheless, this study indicates that MERS-CoV spike, but not
HKU4 spike, has adapted to use human cellular proteases
and thus has evolved the ability to mediate virus entry into
human cells.
These findings provide critical insight into the current MERS-
CoV infections and raises concerns over potential future bat
coronavirus infections in humans. DPP4-recognizing bat coro-
naviruses such as HKU4 pose a threat to human health because
their spikes can potentially adapt to use human DPP4 and hu-
man cellular proteases for human cell entry. Viral adaptation to
human receptors enhances viral attachment to human cells,
whereas viral adaptation to human cellular proteases reduces
viral dependence on the extracellular environment. Both adap-
tation processes can facilitate coronaviruses to expand their host
ranges and tropisms. These evolutionary changes may have al-
ready taken place during the bat-to-human transmission of
MERS-CoV. Recent findings suggest that MERS-CoV has been
circulating in camels for some time (5, 6, 36, 37). Viral adapta-
tions to camel cells could have been an intermediate step toward
viral adaptations to human cells. Regardless of whether the
transmission to humans came directly from bats or indirectly
through camels, the eventual viral adaptations to human cells
may have contributed to the increased replication, transmission,
and pathogenesis of MERS-CoV in humans. Our findings
enhance understanding of the likely causes of MERS-CoV
infections in humans, the potential health risks associated with
DPP4-recognizing bat coronaviruses, and the mechanisms of
cross-species transmissions of animal viruses in general.
Materials and Methods
Cell Lines. The HEK293T (human embryonic kidney), MRC-5 (human lung), and
Tb1-Lu (Triatoma brasiliensis bat lung) cells were obtained from ATCC (www.
atcc.org). Huh-7 (human liver) and Calu-3 (human lung) cells were kindly
provided by Charles M. Rice at Rockefeller University and Chien-Te K. Tseng
at the University of Texas Medical Branch, respectively. These cell lines were
maintained in Dulbecco’s modified Eagle medium, supplemented with 10%
FBS, 2 mM L-glutamine, and 1% penicillin/streptomycin (Life Technologies
Inc, Grand Island, NY).
Protein Expression and Purification. The S1 domains of MERS-CoV (residues
367–588; GenBank accession no. AFS88936.1), HKU4 (residues 372–593;
GenBank accession no. ABN10839.1), HKU5 (residues 375–586; GenBank ac-
cession no. ABN10875.1), and SARS-CoV (residues 306–527; GenBank acces-
sion no. NC_004718) were expressed and purified as previously described
(14, 22). Briefly, the coronavirus S1 domains containing an N-terminal honey
bee melittin signal peptide and a C-terminal His6 tag were expressed in in-
sect cells using the Bac-to-Bac expression system (Life Technologies Inc), se-
creted to cell culture medium, and purified sequentially on HiTrap nickel-
chelating HP column and Superdex 200 gel filtration column (GE Healthcare,
Pittsburgh, PA). Fc-tagged coronavirus S1 domains were obtained by fusion
of the human IgG4 Fc region to the C terminus of the proteins and were
expressed using the same procedure as for the His6-tagged S1 domain. The
Fc-tagged S1 domains were purified sequentially on a HiTrap Protein G HP
column and Superdex 200 gel filtration column.
hDPP4 ectodomain (residues 39–766; GenBank accession no. NP_001926.2)
and bDPP4 ectodomain (residues 36–760; GenBank accession no. KC249974)
containing an N-terminal human CD5 signal peptide and a C-terminal His6
tag were expressed and purified using the same procedure as for His6-tag-
ged coronavirus S1 domains.
AlphaScreen Protein–Protein Binding Assay. The interactions between dif-
ferent coronavirus S1 domains and hDPP4 or bDPP4 were measured using
AlphaScreen, as previously described (38, 39). Briefly, each of the Fc-tagged
coronavirus S1 domains at 3 nM final concentrations was mixed with 100 nM
His6-tagged hDPP4 or bDPP4 in 1/2 AreaPlate (PerkinElmer, Waltham, MA)
for 1 h at room temperature. AlphaScreen Nickel Chelate Donor Beads and
AlphaScreen protein A acceptor beads (PerkinElmer) were added to the
mixtures at final concentrations of 5 μg/mL The mixtures were incubated at
room temperature for 1 h and protected from light. The assay plates were
read in an EnSpire plate reader (PerkinElmer).
Pull-Down Assay. Protein pull-down assay was carried out as previously de-
scribed (14). Briefly, 5 μg His6-tagged hDPP4 or bDPP4 was mixed with each
of the 5 μg Fc-tagged coronavirus S1 domains. The formed complex was
precipitated using nickel-nitrilotriacetic acid agarose (Thermo Scientific,
Waltham, MA). The DPP4 and coronavirus S1 domains were separated by SDS/
PAGE and detected by anti-His6 and anti-human IgG4 Fc antibodies (Santa
Cruz Biotechnology, Dallas, TX), respectively.
Dot Blot Hybridization Assay. Dot blot hybridization assay was carried out as
previously described (40). Briefly, 10 μg each of the Fc-tagged coronavirus S1
domains was dotted onto a nitrocellulose membrane. The membranes were
dried completely and blocked with 5% skim milk at 37 °C for 1 h. Next, 25 μg/mL
His6-tagged hDPP4 or bDPP4 was preincubated alone or with 20 μg/mL goat
anti-hDPP4 polyclonal antibodies (R&D Systems, Minneapolis, MN) at 37 °C for
1 h, added to the membrane, and incubated at 4 °C overnight. The membrane
was then washed five times with phosphate-buffered saline with Tween-20
(PBST), incubated with anti-His6 mouse monoclonal IgG1 HRP conjugate antibody
(Santa Cruz biotechnology) at 37 °C for 2 h, and washed five times with PBST.
Finally, the bound proteins were detected using ECL plus (GE Healthcare).
Inhibition of MERS-CoV-Spike-Mediated Pseudovirus Entry by HKU4 RBD.
Pseudovirus cell entry assay was carried out as previously described (31).
Briefly, MERS-CoV-spike-pseudotyped retroviruses expressing a luciferase
reporter gene were prepared by cotranfecting HEK293T cells with a plasmid
carrying Env-defective, luciferase-expressing HIV-1 genome (pNL4-3.luc.R-E-)
and a plasmid encoding MERS-CoV spike protein. The produced pseudovirus
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particles were harvested 72 h after transfection. HEK293T cells transiently
expressing hDPP4 or bDPP4 were preincubated with gradient concentrations
of each of the purified coronavirus S1 domains for 1 h at 37 °C and then
infected by equal amounts of MERS-CoV-spike-pseudotyped retrovirus par-
ticles. After incubation for 5 h at 37 °C, medium was changed and cells were
incubated for an additional 60 h. Cells were then washed with PBS and lysed.
Aliquots of cell lysates were transferred to Optiplate-96 (PerkinElmer), fol-
lowed by addition of luciferase substrate. Relative light units were measured
using EnSpire plate reader (PerkinElmer).
HKU4-Spike-Mediated Pseudovirus Entry into Human and Bat Cells. Retro-
viruses pseudotyped with MERS-CoV spike, HKU4 spike, or no spike (mock)
were incubatedwith gradient concentrations of TPCK-treated trypsin (Sigma-
Aldrich, St. Louis, MO) for 10 min at 25 °C, and 100 μg/mL soybean trypsin
inhibitor (Sigma-Aldrich) was then added to stop the proteolysis reactions.
Trypsin-treated pseudoviruses were then used to spin-infect HKE293T cells
(transiently expressing hDPP4, bDPP4, or no DPP4), Huh-7 cells (transiently
expressing TMPRSS2 or no TMPRSS2), Calu-3 cells, MRC-5 cells, or Tb1-Lu cells
(transiently expressing hDPP4, bDPP4, or no DPP4) in 96-well plates at 1200 × g
for 2 h at 4 °C. After incubation for 5 h at 37 °C, mediumwas changed. Cells were
incubated for an additional 60 h. The cells were then lysed and measured for
luciferase activity.
Neutralization of HKU4-Spike-Mediated Pseudovirus Entry by Anti-hDPP4
Antibodies. HEK293T cells expressing hDPP4, bDPP4, or no DPP4 were pre-
incubated with 0, 2 μg/mL, or 20 μg/mL goat anti-hDPP4 polyclonal antibodies
(R&D Systems) at 37 °C for 1 h and then infected by equal amounts of MERS-
CoV-spike-pseudotyped retroviruses with no trypsin treatment or HKU4-
spike-pseudotyped retroviruses after trypsin treatment. The infection pro-
cedure was the same as described earlier.
Protease Processing of MERS-CoV- or HKU4-Spike-Packaged Pseudoviruses.
Retroviruses pseudotyped with MERS-CoV spike, HKU4 spike, or no spike
(mock) were incubated with gradient concentrations of TPCK-treated trypsin
(Sigma-Aldrich) for 10 min at 25 °C, and 100 μg/mL soybean trypsin inhibitor
(Sigma-Aldrich) was then added to stop the proteolysis reactions. Trypsin-
treated pseudoviruses were concentrated in an Amicon Ultracentrifuge filter
unit with 100-kDa cutoff (EMD Millipore, Billerica, MA). The pseudovirus
samples were then subjected to Western blot analysis. The His6-tagged
spikes were detected by antibody against their C-terminal His6 tag.
Inhibition of Pseudovirus Entry into Human Cells by Endosome Inhibitors. Huh-7
cells were preincubated with 8 or 40 mM NH4Cl (Sigma-Aldrich) or 4 or 20 μM
E-64d (Sigma-Aldrich) at 37 °C for 1 h and then infected by HKU4- or MERS-
CoV-spike-pseudotyped retroviruses that had been pretreated or not pre-
treated with trypsin. The infection procedure was the same as described
earlier. Huh-7 cells infected by retroviruses pseudotyped with no spike
(mock) were used as control.
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